Back to today’s briefing

Story perspectives

New Zealand Allows Psychiatrists to Prescribe Psilocybin for Depression

6/20/2025

45 9

Summary

Story summary

In a groundbreaking move, New Zealand's Medsafe has granted psychiatrists the authority to prescribe psilocybin for patients battling treatment-resistant depression. This historic decision, the first of its kind beyond research settings, comes with stringent guidelines for clinical assessments and reporting. While no psilocybin products are yet approved, Medsafe is working on expanding access for more healthcare practitioners.

1 of 1

Story summary

In a groundbreaking move, New Zealand's Medsafe has granted psychiatrists the authority to prescribe psilocybin for patients battling treatment-resistant depression. This historic decision, the first of its kind beyond research settings, comes with stringent guidelines for clinical assessments and reporting. While no psilocybin products are yet approved, Medsafe is working on expanding access for more healthcare practitioners.